logo
Plus   Neg
Share
Email

Macy's Cuts FY19 Adj. EPS Outlook - Quick Facts

While reporting its financial results for the second quarter, Macy's, Inc. (M) on Wednesday lowered its adjusted earnings guidance for the full-year 2019, while reaffirming sales annual sales outlook.

For fiscal 2019, the company slashed its adjusted earnings guidance to a range of $2.85 to $3.05 per share from the previous forecast in the range of $3.05 to $3.25 per share.

However, the company continues to project net sales to be approximately flat with the prior year and full-year comparable sales for both, owned plus licensed basis and owned basis to be flat to up 1 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $3.07 per share on a revenue decline of 0.30 percent to $24.89 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Berkshire Hathaway Inc. (BRK.A, BRK.B) announced Wednesday that its CEO billionaire Warren Buffett contributed about 15.97 million "B" shares of Berkshire, valued at about $2.9 billion, to five philanthropies on Tuesday. The shares were given to the following foundations: Bill and Melinda Gates Foundation,... India-based Lupin Pharmaceuticals Inc. announced a recall of all batches of type 2 diabetes medication Metformin Hydrochloride Extended-Release Tablets, citing detection of N-Nitrosodimethylamine or NDMA, a probable human carcinogen. The move comes after many other drug companies called back Metformin tablets after the U.S. Food and Drug Administration or FDA recommended over NDMA concerns. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased.
Follow RTT